IMPLEMENTING DIGITAL TWINS FOR CANCER THERAPY SIMULATION: GENETIC-BASED MEDICAL PERSONALIZATION
Thailand 
Brazil Brazil 
Indonesia 
Article Sidebar
-
Artificial Intelligence, Cancer Therapy, Digital Twins
Abstract
because substantial genetic heterogeneity, dynamic tumor evolution, and variable treatment responses limit the effectiveness of standardized clinical protocols. This study aimed to evaluate the implementation of Digital Twins for cancer therapy simulation and to examine their contribution to genetic-based medical personalization and clinical decision support. A mixed-methods sequential explanatory design was employed involving 480 patients treated at tertiary oncology centers. Quantitative analyses included descriptive statistics, structural equation modeling, survival analysis, mediation and moderation analyses, whereas qualitative evidence was obtained through semi-structured interviews, clinical observations, multidisciplinary case reviews, and document analysis. Findings demonstrated that Digital Twin-assisted treatment planning significantly improved simulation accuracy, treatment response prediction, therapeutic precision, physician decision confidence, and multidisciplinary coordination while reducing anticipated adverse treatment events. Results indicate that Digital Twin technology provides a comprehensive precision oncology framework by integrating computational intelligence, genomic medicine, and real-time clinical information to optimize individualized cancer therapy, improve evidence-based decision-making, and enhance long-term patient outcomes while supporting the broader implementation of personalized medicine.
Full text article
References
Addissouky, T. A. (2024). Latest advances in hepatocellular carcinoma management and prevention through advanced technologies. Egyptian Liver Journal, 14(1). https://doi.org/10.1186/s43066-023-00306-3
Alcazer, V. (2024). Evaluation of a machine-learning model based on laboratory parameters for the prediction of acute leukaemia subtypes: A multicentre model development and validation study in France. Lancet Digital Health, 6(5). https://doi.org/10.1016/S2589-7500(24)00044-X
Allen, A. M. (2024). Envisioning how to advance the MASH field. Nature Reviews Gastroenterology and Hepatology, 21(10), 726–738. https://doi.org/10.1038/s41575-024-00938-9
Argenziano, M. E. (2024). Epidemiology, pathophysiology and clinical aspects of Hepatocellular Carcinoma in MAFLD patients. Hepatology International, 18(Query date: 2026-07-12 15:19:24), 922–940. https://doi.org/10.1007/s12072-024-10692-4
Bergstrom, E. N. (2024). Deep Learning Artificial Intelligence Predicts Homologous Recombination Deficiency and Platinum Response From Histologic Slides. Journal of Clinical Oncology, 42(30), 3550–3560. https://doi.org/10.1200/JCO.23.02641
Bhange, M. (2025). Convergence of nanotechnology and artificial intelligence in the fight against liver cancer: A comprehensive review. Discover Oncology, 16(1). https://doi.org/10.1007/s12672-025-01821-y
Chan, Y. T. (2024). Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma. Molecular Cancer, 23(1). https://doi.org/10.1186/s12943-024-02101-z
Chen, X. (2024). Development of Polymethine Dyes for NIR-II Fluorescence Imaging and Therapy. Advanced Healthcare Materials, 13(16). https://doi.org/10.1002/adhm.202304506
Datta, S. (2024). AutoCriteria: A generalizable clinical trial eligibility criteria extraction system powered by large language models. Journal of the American Medical Informatics Association, 31(2), 375–385. https://doi.org/10.1093/jamia/ocad218
El-Tanani, M. (2025). Deciphering the Role of Cancer Stem Cells: Drivers of Tumor Evolution, Therapeutic Resistance, and Precision Medicine Strategies. Cancers, 17(3). https://doi.org/10.3390/cancers17030382
Emens, L. A. (2024). Challenges and opportunities in cancer immunotherapy: A Society for Immunotherapy of Cancer (SITC) strategic vision. Journal for Immunotherapy of Cancer, 12(6). https://doi.org/10.1136/jitc-2024-009063
Fountzilas, E. (2025). Convergence of evolving artificial intelligence and machine learning techniques in precision oncology. Npj Digital Medicine, 8(1). https://doi.org/10.1038/s41746-025-01471-y
Giansanti, D. (2025). Exploring the Potential of Digital Twins in Cancer Treatment: A Narrative Review of Reviews. Journal of Clinical Medicine, 14(10). https://doi.org/10.3390/jcm14103574
Greening, D. W. (2025). Clinical relevance of extracellular vesicles in cancer—Therapeutic and diagnostic potential. Nature Reviews Clinical Oncology, 22(12), 924–952. https://doi.org/10.1038/s41571-025-01074-2
Hijazi, A. (2024). Digital Pathology for Better Clinical Practice. Cancers, 16(9). https://doi.org/10.3390/cancers16091686
Huang, Y. H. (2025). Longitudinal MRI-Driven Multi-Modality Approach for Predicting Pathological Complete Response and B Cell Infiltration in Breast Cancer. Advanced Science, 12(12). https://doi.org/10.1002/advs.202413702
Keyl, J. (2025). Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligence. Nature Cancer, 6(2), 307–322. https://doi.org/10.1038/s43018-024-00891-1
Kijowska, J. (2024). Epidemiology, Diagnostics, and Therapy of Oral Cancer—Update Review. Cancers, 16(18). https://doi.org/10.3390/cancers16183156
Li, J. (2025). Drug resistance in cancer: Molecular mechanisms and emerging treatment strategies. Molecular Biomedicine, 6(1). https://doi.org/10.1186/s43556-025-00352-w
Mao, Y. (2025). Emerging artificial intelligence-driven precision therapies in tumor drug resistance: Recent advances, opportunities, and challenges. Molecular Cancer, 24(1). https://doi.org/10.1186/s12943-025-02321-x
Mohamed, Y. A. (2025). Decoding the black box: Explainable AI (XAI) for cancer diagnosis, prognosis, and treatment planning-A state-of-the art systematic review. International Journal of Medical Informatics, 193(Query date: 2026-07-12 15:19:24). https://doi.org/10.1016/j.ijmedinf.2024.105689
Oh, Y. (2024). LLM-driven multimodal target volume contouring in radiation oncology. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-53387-y
Oikonomou, E. K. (2025). Artificial Intelligence-Enhanced Risk Stratification of Cancer Therapeutics-Related Cardiac Dysfunction Using Electrocardiographic Images. Circulation Cardiovascular Quality and Outcomes, 18(1). https://doi.org/10.1161/CIRCOUTCOMES.124.011504
Pail, O. (2025). Cancer vaccines and the future of immunotherapy. Lancet, 406(10499), 189–202. https://doi.org/10.1016/S0140-6736(25)00553-7
Patil, V. M. (2024). Experimental and computational models to understand protein-ligand, metal-ligand and metal-DNA interactions pertinent to targeted cancer and other therapies. European Journal of Medicinal Chemistry Reports, 10(Query date: 2026-07-12 15:19:24). https://doi.org/10.1016/j.ejmcr.2024.100133
Schmidl, B. (2024). Assessing the use of the novel tool Claude 3 in comparison to ChatGPT 4.0 as an artificial intelligence tool in the diagnosis and therapy of primary head and neck cancer cases. European Archives of Oto Rhino Laryngology, 281(11), 6099–6109. https://doi.org/10.1007/s00405-024-08828-1
Shi, X. (2024). Development and validation of a web-based artificial intelligence prediction model to assess massive intraoperative blood loss for metastatic spinal disease using machine learning techniques. Spine Journal, 24(1), 146–160. https://doi.org/10.1016/j.spinee.2023.09.001
Tiwari, A. (2025). Current AI technologies in cancer diagnostics and treatment. Molecular Cancer, 24(1). https://doi.org/10.1186/s12943-025-02369-9
Tong, X. (2024). Deep representation learning of chemical-induced transcriptional profile for phenotype-based drug discovery. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-49620-3
Truhn, D. (2024). Large language models and multimodal foundation models for precision oncology. Npj Precision Oncology, 8(1). https://doi.org/10.1038/s41698-024-00573-2
Unger, M. (2024). Deep learning in cancer genomics and histopathology. Genome Medicine, 16(1). https://doi.org/10.1186/s13073-024-01315-6
Wang, Q. (2025). Breakthroughs and challenges of organoid models for assessing cancer immunotherapy: A cutting-edge tool for advancing personalised treatments. Cell Death Discovery, 11(1). https://doi.org/10.1038/s41420-025-02505-w
Witten, J. (2025). Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy. Nature Biotechnology, 43(11), 1790–1799. https://doi.org/10.1038/s41587-024-02490-y
Wongvibulsin, S. (2024). Current State of Dermatology Mobile Applications with Artificial Intelligence Features. JAMA Dermatology, 160(6), 646–650. https://doi.org/10.1001/jamadermatol.2024.0468
Xiong, X. (2025). Breast cancer: Pathogenesis and treatments. Signal Transduction and Targeted Therapy, 10(1). https://doi.org/10.1038/s41392-024-02108-4
Youssef, E. (2025). Exosomes in Precision Oncology and Beyond: From Bench to Bedside in Diagnostics and Therapeutics. Cancers, 17(6). https://doi.org/10.3390/cancers17060940
Zhao, Y. (2025). Deep learning using histological images for gene mutation prediction in lung cancer: A multicentre retrospective study. Lancet Oncology, 26(1), 136–146. https://doi.org/10.1016/S1470-2045(24)00599-0
